MK-677 (Ibutamoren)
Growth Hormone Secretagogue (Non-Peptide, Oral GHS)researchAlso known as: Ibutamoren, Ibutamoren Mesylate, MK-0677, L-163,191, Nutrobal
An orally active, non-peptide growth hormone secretagogue that mimics ghrelin to raise GH and IGF-1 levels for up to 24 hours per dose, with notable effects on sleep, appetite, and body composition.
Overview
MK-677 (Ibutamoren) is technically not a peptide but a non-peptide, orally bioavailable growth hormone secretagogue that mimics the action of ghrelin by binding to the GHS-R1a receptor. It is included in peptide discussions because it activates the same pathway as peptide GHRPs but can be taken orally rather than injected. MK-677 produces sustained elevation of GH and IGF-1 levels for up to 24 hours after a single oral dose, without significantly affecting cortisol levels. Originally developed by Merck for treatment of GH deficiency, frailty, and osteoporosis, it has been studied in multiple clinical trials but never received FDA approval. It is one of the most popular compounds in the biohacking and bodybuilding communities due to its oral convenience, potent sleep-enhancing properties, and significant effects on body composition. Notable considerations include strong appetite stimulation and potential effects on blood glucose and insulin sensitivity.
Mechanism of Action
MK-677 acts through: (1) Mimicking endogenous ghrelin by binding to the GHS-R1a receptor on pituitary somatotrophs, stimulating GH release; (2) Produces pulsatile GH release pattern, preserving physiological secretion dynamics; (3) Raises IGF-1 levels by 40-90% with sustained use, through increased GH-mediated hepatic IGF-1 synthesis; (4) Does not suppress the hypothalamic-pituitary axis or natural GH production; (5) Activates ghrelin pathways in the hypothalamus, strongly stimulating appetite (orexigenic effect); (6) Increases duration and quality of REM and stage 4 (deep) sleep; (7) Unlike injected GHRPs, bypasses first-pass metabolism issues due to its non-peptide structure.
Molecular Formula
C27H36N4O5S
Molecular Weight
528.66 g/mol
Dosage Protocols
Dose Range
10mg – 25mg
Frequency
Once daily
Route
oral
Cycle Length
8-12 weeks on, 4 weeks off (or ongoing with monitoring)
Take before bed to enhance deep sleep and coincide with natural nocturnal GH surge. Most users find 15-25mg optimal. Strong appetite stimulation may occur 30-60 minutes after dosing.
Source: Clinical trial data and community protocols
🧮 Personalized Dosage Calculator
💰 Estimated Pricing
Typical Supply
25mg capsules, 30ct
Last Updated
2026-02
Ibutamoren. Oral GH secretagogue (not a peptide technically). Research: $30-60. Very popular. Increases hunger and water retention.
⚠️ Prices are estimates based on publicly available data and may vary significantly by vendor, location, and prescription status. This is not medical or financial advice.
Side Effects
| Effect | Severity |
|---|---|
| Increased appetite | moderate |
| Water retention / bloating | mild |
| Lethargy / drowsiness | mild |
| Numbness / tingling in extremities | mild |
| Elevated fasting blood glucose | moderate |
| Insulin resistance | moderate |
| Joint pain | mild |
| Vivid dreams | mild |
Pros & Cons
Oral administration — no injections needed, unique among GH secretagogues
Dramatically improves sleep quality, particularly deep sleep stages
Sustained 24-hour GH/IGF-1 elevation from a single daily dose
Extensive clinical trial data in humans (multiple Phase 2 studies)
Does not suppress natural GH production or desensitize the pituitary
Strong appetite stimulation can lead to unwanted weight gain if not managed
Can impair insulin sensitivity and raise fasting blood glucose with chronic use
Water retention and bloating are common, especially in the first few weeks
Not FDA-approved despite extensive clinical research
Effects on blood sugar make it potentially risky for pre-diabetic individuals
Research Studies
🩸 Blood Work
IGF-1
MK-677 produces sustained IGF-1 elevation — must monitor
Fasting Blood Glucose
MK-677 is notorious for impairing insulin sensitivity
Fasting Insulin
Insulin resistance is one of the most common side effects
HbA1c
Long-term glucose marker — essential for extended MK-677 use
Prolactin
MK-677 can elevate prolactin levels
Cortisol
Ghrelin mimetic can affect cortisol
Liver Function Panel (AST/ALT)
Oral compound — hepatic processing
Oral ghrelin mimetic with 24-hour GH elevation. High risk of insulin resistance and blood sugar issues, especially with extended use. Pre-diabetic or diabetic individuals should avoid. Blood glucose monitoring is critical.
Legal Status
Not FDA-approved. Sold as a research chemical. Not scheduled as a controlled substance in most countries. Banned by WADA. Available widely online, but regulatory status varies by jurisdiction.
💬 Community Experiences
Share Your ExperienceGreat for appetite increase and sleep improvement. Put on about 8 lbs of lean mass. The hunger can be intense though — not ideal if you're trying to cut. Oral dosing is convenient.
Sleep quality noticeably better — vivid dreams and feeling more rested. Some water retention and increased appetite. Good for a bulk phase, would not recommend during a cut.
Water retention was significant for me. Gained weight but hard to tell how much is actual muscle vs water. Blood sugar went up slightly which concerned me. Monitoring closely.
Hunger increase was too much for me at 25mg. Dropped to 12.5mg and it's more manageable. Sleep improved but the metabolic effects need watching. Get bloodwork.
⚠️ Individual experiences may vary. These are user-submitted reports for informational purposes only. Always consult a healthcare professional before starting any peptide protocol.
Readers Also Viewed
Semaglutide
99An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, producing significant weight loss of 15-17% body weight in clinical trials.
BPC-157
98A 15-amino acid synthetic peptide derived from human gastric juice that promotes healing of tendons, ligaments, muscles, gut lining, and other tissues through multiple regenerative pathways.
Tirzepatide
97A first-in-class dual GIP/GLP-1 receptor agonist that produces up to 22.5% body weight loss, approved for type 2 diabetes and obesity management.
CJC-1295 + Ipamorelin (Combo)
95The most popular growth hormone peptide combination, pairing a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) for synergistic GH release with minimal side effects.
Related Peptides
Semaglutide
An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, producing significant weight loss of 15-17% body weight in clinical trials.
BPC-157
A 15-amino acid synthetic peptide derived from human gastric juice that promotes healing of tendons, ligaments, muscles, gut lining, and other tissues through multiple regenerative pathways.
Tirzepatide
A first-in-class dual GIP/GLP-1 receptor agonist that produces up to 22.5% body weight loss, approved for type 2 diabetes and obesity management.
CJC-1295 + Ipamorelin (Combo)
The most popular growth hormone peptide combination, pairing a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) for synergistic GH release with minimal side effects.